![]() |
市场调查报告书
商品编码
1757081
专家问答:医疗事务发展方向及未来发展趋势如何?Expert Q&A: Where Medical Affairs is Heading - and How to Keep Up |
未来十年,在技术进步和医疗保健需求不断增长的推动下,医疗事务领域将迎来变革。
主要趋势包括:人工智慧 (AI) 与机器学习 (ML) 的整合,以增强数据分析和个人化医疗;远距医疗和远端监控等数位健康技术的兴起;以及更加重视真实世界证据 (RWE),以深入了解不同人群的治疗效果。
这些变化需要数位健康和数据领域的新专业知识,以及更智慧的协作,以改善决策、改善结果并提高效率。
檔案报告是基于独立而简洁的分析,这些分析源自于专有的产业研究以及对产业思想领袖的深入访谈。这些报告深入分析了製药企业高阶主管需要了解的关键趋势和市场发展,以应对未来的机会和课题。每份报告的重点都基于二手文献综述和已发现的知识差距。基于这些初步研究,我们制定了基于证据、专家意见的讨论指南,以确保研究能够解答最重要的问题。此外,我们采用严格的筛选标准,确保受访者有足够的经验、知识和资格就该主题发表意见。
FirstWord Reports 是值得信赖的行业领导者,专注于製药业,为生物製药专业人士和决策者提供深入、可操作的洞察。我们深厚的行业知识使我们能够提供相关且有价值的洞察,帮助我们的客户掌握新兴趋势并有效解决复杂课题。凭藉广泛的研究以及来自领先专家和关键意见领袖的独立、公正的见解,我们的报告能够提供您所需的准确性和可靠性。独家访谈和数据,加上持续的市场监测,让您可以全面洞察市场动态。我们的报告涵盖 40 多个活跃疾病领域,汇集医生情报(包括 KOL 洞察和定量医生调查),以及行业专家对医疗事务、数位健康、销售与市场营销、市场准入及其他领域问题的看法,助您做出更明智的数据驱动决策,在快速变化的行业中保持竞争力。
The next decade promises transformative changes in medical affairs, driven by technological advancements and evolving healthcare needs.
Key trends include the integration of AI and machine learning (ML) for enhanced data analysis and personalised medicine, the rise of digital health technologies like telehealth and remote monitoring, and a growing focus on real-world evidence (RWE) for insights into therapy effectiveness across diverse populations.
These changes call for new expertise in digital health and data, paired with smarter collaboration-to boost decisions, outcomes and efficiency.
Dossier reports are developed from independent and concise analysis derived from original industry surveys and in-depth interviews with industry thought leaders. Reports analyse in detail significant developments and market trends that pharma executives need to understand if they are to manage the opportunities and challenges that lie ahead. The focus of each report is defined by a review of the secondary literature and any knowledge gaps identified. Based on this initial research, an evidence-based and expert-informed discussion guide is developed to ensure the research answers the most critical questions. Additionally, robust screening criteria are established to ensure that those interviewed are qualified in terms of their experience, knowledge and stature to speak on the topic.
FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.